Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida

January 18, 2024

https://www.globenewswire.com/news-release/2024/01/18/2811506/0/en/Vaxxinity-Announces-Collaboration-on-Space-Medicine-Research-with-University-of-Central-Florida.html

CAPE CANAVERAL, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced a collaboration with the University of Central Florida (UCF) to advance space medicine research. The research, funded by a grant from the State of Florida, aims to further the development of Vaxxinity’s active immunotherapies to prevent and mitigate muscle and bone wasting, which are well known health challenges related to long-term spaceflight, and which share biological mechanisms implicated in highly prevalent age-related diseases.

Read more at globenewswire.com

Related news for (VAXX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.